Jingping Yu
Impact in
-
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Gastric Cancer Management and Outcomes 8
- Lung Cancer Diagnosis and Treatment 5
- Lung Cancer Treatments and Mutations 5
- Surgery 14
- Esophageal Cancer Research and Treatment 13
- Co-authors
- Zhiqiang Sun (13 shared papers)Jianlin Wang (17 shared papers)Zhenyan Song (3 shared papers)Fenju Liu (3 shared papers)Jinwen Ge (1 shared paper)Ping Li (1 shared paper)Yayun Cui (1 shared paper)Quan Zhang (1 shared paper)
In The Last Decade
Jingping Yu
41 papers receiving 352 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 65
- Oncology 91
- Biological Psychiatry 8
- Complementary and alternative medicine 23
- Pharmacology 20
Countries citing papers authored by Jingping Yu
This map shows the geographic impact of Jingping Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingping Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingping Yu more than expected).
Fields of papers citing papers by Jingping Yu
This network shows the impact of papers produced by Jingping Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingping Yu. The network helps show where Jingping Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jingping Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Interleukin-22 secreted by cancer-associated fibroblasts regulates the proliferation and metastasis of lung cancer cells via the PI3K-Akt-mTOR signaling pathway. | 2019 | 50 |
| 2 | 2019 | 43 | |
| 3 | 2015 | 30 | |
| 4 | 2018 | 26 | |
| 5 | 2011 | 18 | |
| 6 | 2011 | 13 | |
| 7 | 2018 | 12 | |
| 8 | 2020 | 12 | |
| 9 | 2014 | 11 | |
| 10 | KIF22 promotes progress of esophageal squamous cell carcinoma cells and is negatively regulated by miR-122. | 2021 | 11 |
| 11 | 2017 | 11 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 9 | |
| 14 | 2020 | 9 | |
| 15 | 2015 | 8 | |
| 16 | 2020 | 8 | |
| 17 | 2023 | 7 | |
| 18 | 2022 | 7 | |
| 19 | 2017 | 6 | |
| 20 | 2022 | 5 |
About Jingping Yu
Jingping Yu is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Oncology and Cancer Research, having authored 47 papers that have together received 356 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (13 papers), Gastric Cancer Management and Outcomes (8 papers), Angiogenesis and VEGF in Cancer (6 papers), Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers), Advanced X-ray and CT Imaging (3 papers), Cancer-related Molecular Pathways (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Cancer Research (65 citations), Oncology (91 citations), Biological Psychiatry (8 citations), Complementary and alternative medicine (23 citations) and Pharmacology (20 citations). Jingping Yu has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Zhiqiang Sun, Jianlin Wang, Zhenyan Song, Fenju Liu, Jinwen Ge, Ping Li, Yayun Cui, Quan Zhang, Meiling Sun and Xifa Zhou. Their work appears in journals such as Aging, Medicine, Technology in Cancer Research & Treatment, Radiation Oncology and Optics Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.